Physician profile
Mark C Sultzman
NPI 1841524527
$1,100.10
in general payments reported to CMS, 2019-2025
17 companies · $228 in 2025
The $228 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $77.05 · 2022: $156 · 2023: $313 · 2024: $326 · 2025: $228.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $611 · Travel and Lodging: $158 · Education: $98.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $611.07 |
| Travel and Lodging | $157.77 |
| Education | $98.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $250.46 | 2023-2025 | Iovera, Exparel, Zilretta |
| Abbvie INC. | $131.04 | 2022-2025 | |
| Astrazeneca Pharmaceuticals Lp | $110.98 | 2021-2025 | Farxiga |
| Novo Nordisk INC | $103.59 | 2021-2025 | Ozempic, Rybelsus |
| Medical Device Business Services, INC. | $98.00 | 2024 | |
| Glaxosmithkline, LLC. | $94.83 | 2023-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Janssen Pharmaceuticals, INC | $53.66 | 2022 | |
| Pfizer INC. | $43.98 | 2023-2024 | |
| Dexcom, INC. | $40.85 | 2021-2022 | |
| Amgen INC. | $39.35 | 2025 | Evenity |
| Smith+Nephew, INC. | $39.01 | 2024-2025 | Pico 14, Renasys Touch, "Acticoat 4"" X 4""" |
| Lundbeck LLC | $19.32 | 2025 | Vyepti |
| Biohaven Pharmaceutical Holding Company Ltd. | $17.52 | 2022 | |
| Amarin Pharma, INC. | $16.46 | 2021 | |
| Boston Scientific Corporation | $15.79 | 2025 | Varithena Administration Pack |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $13.71 | 2022 | |
| Lilly USA, LLC | $11.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Sultzman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.